| 英文名称 |
中文名称 |
CAS |
|
Fusidine
|
夫西地酸 |
6990-06-3 |
|
Empagliflozin
|
恩格列净 |
864070-44-0 |
|
PYRIDINE-3-SULFONYL CHLORIDE HYDROCHLORIDE
|
3-吡啶磺酰氯 |
16133-25-8 |
|
Tedizolid phosphate
|
磷酸特地唑胺 |
856867-55-5 |
|
5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine
|
2-甲基-5-(5-溴吡啶-2-基)四氮唑 |
380380-64-3 |
|
Benzyl (4-broMo-3-fluorophenyl)carbaMate
|
N-苄氧羰基-4-溴-3-氟苯胺 |
510729-01-8 |
|
N-[3-fluoro-4-[6-(2-Methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-phenylMethyl ester
|
特地唑咹中间体 |
1220910-89-3 |
|
Tofacitinib
|
托法替尼 |
477600-75-2 |
|
Parecoxib
|
帕瑞昔布 |
198470-84-7 |
|
5-Methyl-3,4-diphenyl- (Parecoxib sodiuM inteMediate)
|
5-甲基-3,4-二苯基异噁唑 |
37928-17-9 |
|
Valdecoxib
|
代他考昔 |
181695-72-7 |
|
5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde
|
沃诺拉赞 |
881677-11-8 |
|
5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile
|
5-(2-氟苯基)-1H-吡咯-3-甲腈 |
1240948-77-9 |
|
PARECOXIB SODIUM
|
帕瑞昔布钠 |
198470-85-8 |
|
5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde
|
5-(2-氟苯基)吡咯-3-甲醛 |
881674-56-2 |
|
2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile
|
2-氯-5-（2-氟苯基）-1H-吡咯-3-甲腈;5-(2-氟苯基)吡咯-3-乙腈 |
1240948-72-4 |
|
(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methanol;TAK438 Impurity 1;Vonoprazan-13;Vonoprazan Impuirty 10
|
富马酸沃诺拉赞杂质15;Vonoprazan Impuirty 10 |
2169271-28-5 |
|
Trelagliptin succinate
|
琥珀酸曲格列汀 |
1029877-94-8 |
|
1H-Pyrrole-3-carboxylic acid, 5-(2-fluorophenyl)-, ethyl ester
|
5-(2-氟苯基)-1H-吡咯-3-羧酸乙酯 |
881674-06-2 |
|
Pro-xylane
|
玻色因;羟丙基四氢吡喃三醇 |
439685-79-7 |
|
L-(+)-Ergothioneine
|
麦角硫因;2-巯基组氨酸甜菜碱 |
497-30-3 |
|
Ectoine
|
依克多因; 四氢甲基嘧啶羧酸 |
96702-03-3 |
